What is Longs Drugs?
Longs Drugs operates as a retail pharmacy chain, distinguished by its enduring identity and culture in Hawaii, a legacy preserved even after its acquisition by CVS Pharmacy in 2008. The company is recognized for its commitment to quality and tradition, extending beyond prescription dispensing to encompass a broader role as a partner in community well-being. This approach reflects deep-rooted island values of loyalty and respect, maintaining a familiar atmosphere and brand presence for its customers.
How much funding has Longs Drugs raised?
Longs Drugs has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Longs Drugs?
The recent debt financing of $150 million, alongside the context of large-scale late-stage funding, suggests Longs Drugs is strategically managing its capital structure to support ongoing operations and potentially future growth initiatives. As part of CVS Pharmacy, the company is positioned to leverage broader corporate resources and healthcare integration strategies. Future developments will likely focus on maintaining its unique market position in Hawaii while aligning with CVS's overarching retail and pharmacy network objectives.
See full Longs Drugs company page
